Convergence Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-508
Closed -$253K 285
2025
Q1
$253K Sell
508
-136
-21% -$67.7K 0.07% 223
2024
Q4
$335K Buy
644
+12
+2% +$6.25K 0.07% 205
2024
Q3
$391K Sell
632
-25
-4% -$15.5K 0.11% 189
2024
Q2
$364K Sell
657
-13
-2% -$7.19K 0.11% 197
2024
Q1
$390K Sell
670
-1
-0.1% -$582 0.15% 163
2023
Q4
$356K Sell
671
-13
-2% -$6.9K 0.19% 117
2023
Q3
$346K Buy
684
+2
+0.3% +$1.01K 0.2% 107
2023
Q2
$356K Sell
682
-22
-3% -$11.5K 0.2% 108
2023
Q1
$406K Buy
704
+6
+0.9% +$3.46K 0.24% 101
2022
Q4
$385K Sell
698
-22
-3% -$12.1K 0.23% 105
2022
Q3
$365K Sell
720
-26
-3% -$13.2K 0.24% 102
2022
Q2
$405K Sell
746
-14
-2% -$7.6K 0.25% 100
2022
Q1
$449K Sell
760
-8
-1% -$4.73K 0.23% 107
2021
Q4
$513K Sell
768
-37
-5% -$24.7K 0.26% 96
2021
Q3
$460K Buy
805
+21
+3% +$12K 0.25% 99
2021
Q2
$396K Sell
784
-532
-40% -$269K 0.17% 131
2021
Q1
$601K Buy
1,316
+472
+56% +$216K 0.27% 93
2020
Q4
$393K Buy
844
+19
+2% +$8.85K 0.2% 113
2020
Q3
$364K Sell
825
-90
-10% -$39.7K 0.13% 201
2020
Q2
$332K Buy
915
+39
+4% +$14.2K 0.11% 191
2020
Q1
$248K Sell
876
-4,435
-84% -$1.26M 0.11% 196
2019
Q4
$1.73M Buy
5,311
+1,246
+31% +$405K 0.49% 63
2019
Q3
$1.18M Sell
4,065
-2,670
-40% -$778K 0.33% 107
2019
Q2
$1.98M Buy
6,735
+5,820
+636% +$1.71M 0.48% 70
2019
Q1
$251K Buy
915
+7
+0.8% +$1.92K 0.05% 245
2018
Q4
$203K Buy
+908
New +$203K 0.05% 293
2018
Q2
Sell
-747
Closed -$154K 852
2018
Q1
$154K Buy
+747
New +$154K 0.02% 306